Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Henryk Barthel; John Seibyl; Adriaan A. Lammertsma; Victor L. Villemagne; Osama Sabri

doi:10.2967/jnumed.119.228346

Research ArticleHot Topics

Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Henryk Barthel, John Seibyl, Adriaan A. Lammertsma, Victor L. Villemagne and Osama Sabri

Journal of Nuclear Medicine August 2020, 61 (8) 1105-1106; DOI: https://doi.org/10.2967/jnumed.119.228346

Henryk Barthel

1Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John Seibyl

2Institute for Neurodegenerative Disorders, New Haven, Connecticut

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adriaan A. Lammertsma

3Department of Radiology and Nuclear Medicine, Vrije Universiteit University Medical Center, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Victor L. Villemagne

4Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Australia; and

5Department of Medicine, University of Melbourne, Heidelberg, Australia

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Osama Sabri

1Department of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Information

vol. 61 no. 8 1105-1106

DOI

https://doi.org/10.2967/jnumed.119.228346

PubMed

32414946

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication April 20, 2020
Accepted for publication April 29, 2020
Published online August 3, 2020.

Article Versions

previous version (May 15, 2020 - 05:25).
You are viewing the most recent version of this article.

Author Information

Statistics from Altmetric.com

Cited By...

6 Citations
8 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

Gérard N Bischof, Alessandra Dodich, Marina Boccardi, Thilo van Eimeren, Cristina Festari, Henryk Barthel, Oskar Hansson, Agneta Nordberg, Rik Ossenkoppele, Osama Sabri, B Frisoni G Giovanni, Valentina Garibotto, Alexander Drzezga

European Journal of Nuclear Medicine and Molecular Imaging 2021 48 7
First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease

Henryk Barthel

Journal of Nuclear Medicine 2020 61 10
α-Synuclein PET and Parkinson Disease Therapeutic Trials: Ever the Twain Shall Meet?

John P. Seibyl

Journal of Nuclear Medicine 2022 63 10
The approval of a disease-modifying treatment for Alzheimer’s disease: impact and consequences for the nuclear medicine community

Valentina Garibotto, Nathalie L. Albert, Henryk Barthel, Bart van Berckel, Ronald Boellaard, Matthias Brendel, Diego Cecchin, Ozgul Ekmekcioglu, Elsmarieke van de Giessen, Eric Guedj, Adriaan A. Lammerstma, Franck Semah, Tatjana Traub-Weidinger, Donatienne Van Weehaeghe, Silvia Morbelli

European Journal of Nuclear Medicine and Molecular Imaging 2021 48 10
Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders

John P. Seibyl

Journal of Nuclear Medicine 2023 64 1
Deciphering Drug Targets and Actions with Single-Cell and Spatial Resolution

Zhengyuan Pang, Benjamin F. Cravatt, Li Ye

Annual Review of Pharmacology and Toxicology 2024 64 1
Hybrid PET/MR Neuroimaging

Maria Rosana Ponisio, Pooya Iranpour, Tammie L. S. Benzinger

2022
Atkinson's Principles of Clinical Pharmacology

Owen Carmichael

2022

Article usage

Article usage: May 2020 to December 2024

	Abstract	Full	Pdf
May 2020	4	0	72
Jun 2020	1	0	21
Jul 2020	0	0	3
Aug 2020	4	118	107
Sep 2020	2	21	31
Oct 2020	0	61	35
Nov 2020	0	31	20
Dec 2020	0	42	28
Jan 2021	0	29	14
Feb 2021	0	26	13
Mar 2021	0	34	18
Apr 2021	0	39	7
May 2021	0	78	9
Jun 2021	0	40	4
Jul 2021	0	14	10
Aug 2021	0	13	12
Sep 2021	0	16	5
Oct 2021	0	26	24
Nov 2021	0	20	24
Dec 2021	0	23	4
Jan 2022	0	7	5
Feb 2022	0	10	7
Mar 2022	0	13	11
Apr 2022	0	6	3
May 2022	0	21	15
Jun 2022	0	14	6
Jul 2022	0	8	7
Aug 2022	0	12	8
Sep 2022	0	7	11
Oct 2022	0	14	12
Nov 2022	0	13	12
Dec 2022	0	9	4
Jan 2023	0	13	6
Feb 2023	0	14	5
Mar 2023	0	20	5
Apr 2023	0	15	10
May 2023	0	20	10
Jun 2023	0	21	7
Jul 2023	0	10	11
Aug 2023	0	11	9
Sep 2023	0	14	8
Oct 2023	0	9	3
Nov 2023	0	14	6
Dec 2023	0	46	8
Jan 2024	0	14	1
Feb 2024	0	10	4
Mar 2024	0	9	3
Apr 2024	0	16	9
May 2024	0	42	4
Jun 2024	0	20	7
Jul 2024	0	16	12
Aug 2024	0	28	11
Sep 2024	0	33	7
Oct 2024	0	19	15
Nov 2024	0	20	7
Dec 2024	0	10	7

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 61, Issue 8

August 1, 2020

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Henryk Barthel, John Seibyl, Adriaan A. Lammertsma, Victor L. Villemagne, Osama Sabri

Journal of Nuclear Medicine Aug 2020, 61 (8) 1105-1106; DOI: 10.2967/jnumed.119.228346

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Henryk Barthel, John Seibyl, Adriaan A. Lammertsma, Victor L. Villemagne, Osama Sabri

Journal of Nuclear Medicine Aug 2020, 61 (8) 1105-1106; DOI: 10.2967/jnumed.119.228346

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders
{alpha}-Synuclein PET and Parkinson Disease Therapeutic Trials: Ever the Twain Shall Meet?
First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease

Google Scholar

Main menu

User menu

Search

Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: May 2020 to December 2024

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles